Arman Ahmadzadeh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Arman Ahmadzadeh has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Alireza Rajaei
Department of Adult Rheumatology, School of Medicine, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2 shared publications - Mohammad Moslemizadeh
Assistant Professor of Rheumatology, Rheumatology Department, Loghman Hakim hospital, Shaheed Beheshti University of Medical Sciences (SBUMC), Tehran, Iran
2 shared publications - Maryam Jalessi
Skull Base Research Center, The Five Senses Health Institute, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
1 shared publication Mina Ebrahimi-Rad
1 shared publicationMohammad Mehdi Emam
1 shared publication- Mohammadmehdi Emam
Assistant Professor of Rheumatology, Rheumatology Department, Loghman Hakim hospital, Shaheed Beheshti University of Medical Sciences (SBUMC), Tehran, Iran
1 shared publication
Latest Publications
- 1 January 2016
- Published by DoNotEdit in Rheumatology Research
- Vol. 1 (1) , 15-19
Accuracy of a fracture risk assessment tool in Iranian osteopenic and osteoporotic women
Objective: Bone mineral densitometry (BMD) has been well known as a practical method in the detection of osteoporosis. However, it is not accurate in the identification of fracture risk in non- osteoporotic patients because of its low sensitivity. Fracture Risk Assessment Tool (FRAX) is a sensitive WHO recommended risk assessment tool for the prediction of the risk of fracture in order to diagnose patients who would benefit the most from pharmacological treatment.Methods: This cross-sectional study included a sample of 361 Iranian women aged 40 to 80 years- old who, for any reason, were referred for humeral BMD. Femoral BMD and FRAX were performed on all of the subjects and the results were compared to one another to figure out the accuracy of FRAX to detect the patients at high risk of fracture.Results: There were 361 participants in the study with a mean age of 56.4 ± 5.5 years, and comprised of 89 (24.7%) osteoporotic (T-score -2.5), 125 (34.7%) osteopenic (T-Score between -1 and -2.5) and 147 (40.7%) subjects with T-score > -1. A 10-year probability of hip fracture of more than 3% was detected in only in six women (1.6%) and a major osteoporotic fracture risk (of higher than 20%) was not detected in any subject.Conclusion: Applying FRAX in osteopenic and osteoporotic Iranian women showed no extra benefit in comparison to using BMD alone. It seems that FRAX is not accurate in our population as it underestimates the number of patients that could benefit from osteoporosis treatment.
- 1 January 2016
- Published by DoNotEdit in Rheumatology Research
- Vol. 1 (1) , 15-19
Accuracy of a fracture risk assessment tool in Iranian osteopenic and osteoporotic women
Objective: Bone mineral densitometry (BMD) has been well known as a practical method in the detection of osteoporosis. However, it is not accurate in the identification of fracture risk in non- osteoporotic patients because of its low sensitivity. Fracture Risk Assessment Tool (FRAX) is a sensitive WHO recommended risk assessment tool for the prediction of the risk of fracture in order to diagnose patients who would benefit the most from pharmacological treatment.Methods: This cross-sectional study included a sample of 361 Iranian women aged 40 to 80 years- old who, for any reason, were referred for humeral BMD. Femoral BMD and FRAX were performed on all of the subjects and the results were compared to one another to figure out the accuracy of FRAX to detect the patients at high risk of fracture.Results: There were 361 participants in the study with a mean age of 56.4 ± 5.5 years, and comprised of 89 (24.7%) osteoporotic (T-score -2.5), 125 (34.7%) osteopenic (T-Score between -1 and -2.5) and 147 (40.7%) subjects with T-score > -1. A 10-year probability of hip fracture of more than 3% was detected in only in six women (1.6%) and a major osteoporotic fracture risk (of higher than 20%) was not detected in any subject.Conclusion: Applying FRAX in osteopenic and osteoporotic Iranian women showed no extra benefit in comparison to using BMD alone. It seems that FRAX is not accurate in our population as it underestimates the number of patients that could benefit from osteoporosis treatment.
- Open Access
- 15 September 2014
- Vol. 28, 94
Comparison of three different osteoporosis risk assessment tools: ORAI (osteoporosis risk assessment instrument), SCORE (simple calculated osteoporosis risk estimation) and OST (osteoporosis self-assessment tool)
Background: SCORE, OST and ORAI risk assessment tools could reduce the cost burden of BMD tests by selecting the high risk patients to osteoporosis. In this study we compared the ability of these risk assessment measures to assess probability of the osteoporosis among post-menopausal women.
- 15 September 2014
- Vol. 28, 94
Open AccessComparison of three different osteoporosis risk assessment tools: ORAI (osteoporosis risk assessment instrument), SCORE (simple calculated osteoporosis risk estimation) and OST (osteoporosis self-assessment tool)
Background: SCORE, OST and ORAI risk assessment tools could reduce the cost burden of BMD tests by selecting the high risk patients to osteoporosis. In this study we compared the ability of these risk assessment measures to assess probability of the osteoporosis among post-menopausal women.